References
- FattuoniCPalmasFNotoAFanosVBarberiniLPerinatal asphyxia: a review from a metabolomics perspectiveMolecules20152047000701625898414
- Herrera-MarschitzMMoralesPLeytonLPerinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteinsNeurotox Res201119460362720645042
- AméJCSpenlehauerCde MurciaGThe PARP superfamilyBioessays200426888289315273990
- MiwaMIdaCYamashitaSTanakaMFujisawaJPoly(ADP-ribose): Structure, Physicochemical Properties and Quantification in vivo, with special reference to poly(ADP-ribose) binding protein modulesCurr Protein Pept Sci201617768369227817744
- HegedűsCVirágLInputs and outputs of poly(ADP-ribosyl)ation: Relevance to oxidative stressRedox Biol201422c97898225460733
- KimMYRegulation of chromatin structure by PARP-1Methods Mol Biol201178022723621870264
- KrausWLHottigerMOPARP-1 and gene regulation: progress and puzzlesMol Aspects Med20133461109112323357755
- BeckCRobertIReina-San-MartinBSchreiberVDantzerFPoly(ADP-ribose) polymerases in double-strand break repair: focus on PARP1, PARP2 and PARP3Exp Cell Res20143291182525017100
- de MurciaGMénissier de MurciaJPoly(ADP-ribose) polymerase: a molecular nick-sensorTrends Biochem Sci19941941721768016868
- Neira-PeñaTRojas-MancillaEMunoz-VioVPerinatal asphyxia leads to PARP-1 overactivity, p65 translocation, IL-1β and TNF-α over-expression, and apoptotic-like cell death in mesencephalon of neonatal rats: prevention by systemic neonatal nicotinamide administrationNeurotox Res201527445346525835215
- HaskóGMableyJGNémethZHPacherPDeitchEASzabóCPoly(ADP-ribose) polymerase is a regulator of chemokine production: relevance for the pathogenesis of shock and inflammationMol Med20028528328912359959
- Allende-CastroCEspina-MarchantPBustamanteDFurther studies on the hypothesis of PARP-1 inhibition as a strategy for lessening the long-term effects produced by perinatal asphyxia: effects of nicotinamide and theophylline on PARP-1 activity in brain and peripheral tissue: nicotinamide and theophylline on PARP-1 activityNeurotox Res2012221799022311271
- DykxhoornDMLiebermanJThe silent revolution: RNA interference as basic biology, research tool, and therapeuticAnnu Rev Med20055640142315660519
- DominskaMDykxhoornDMBreaking down the barriers: siRNA delivery and endosome escapeJ Cell Sci2010123Pt 81183118920356929
- PardridgeWMThe blood-brain barrier: bottleneck in brain drug developmentNeuroRx20052131415717053
- DurandSCimarelliAThe inside out of lentiviral vectorsViruses20113213215922049307
- SrikanthMKesslerJANanotechnology-novel therapeutics for CNS disordersNat Rev Neurol20128630731822526003
- MintzerMASimanekEENonviral vectors for gene deliveryChem Rev2009109225930219053809
- MartinSECaplenNJApplications of RNA interference in mammalian systemsAnnu Rev Genomics Hum Genet200788110817477824
- KimBYRutkaJTChanWCNanomedicineN Engl J Med2010363252434244321158659
- Velasco-AguirreCMoralesFGallardo-ToledoEPeptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approachesInt J Nanomedicine2015104919493626300639
- Velasco-AguirreCMorales-ZavalaFSalas-HuenuleoEImproving gold nanorod delivery to the central nervous system by conjugation to the shuttle Angiopep-2Nanomedicine201712202503251728882086
- MccullyMSanchez-NavarroMTeixidoMGiraltEPeptide Mediated Brain Delivery of Nano- and Submicroparticles: a Synergistic ApproachCurr Pharm Des201824131366137629205110
- KawasakiESPlayerANanotechnology, nanomedicine, and the development of new, effective therapies for cancerNanomedicine20051210110917292064
- DoaneTLBurdaCThe unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapyChem Soc Rev20124172885291122286540
- CabuzuDCirjaAPuiuRGrumezescuAMBiomedical applications of gold nanoparticlesCurr Top Med Chem201515161605161325877087
- DanielMCAstrucDGold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnologyChem Rev2004104129334614719978
- DreadenECAustinLAMackeyMAEl-SayedMASize matters: gold nanoparticles in targeted cancer drug deliveryTher Deliv20123445747822834077
- RaiMIngleAPBirlaSYadavASantosCAStrategic role of selected noble metal nanoparticles in medicineCrit Rev Microbiol20153124
- RodaLGNolanJAKimSUHogue-AngelettiRAIsolation and characterization of chromaffin granules from a pheochromocytoma (PC 12) cell lineExp Cell Res198012811031096157547
- FornaiFLenziPLazzeriGFine ultrastructure and biochemistry of PC12 cells: a comparative approach to understand neurotoxicityBrain Res20071129117419017157274
- JungJYKimWJInvolvement of mitochondrial- and Fas-mediated dual mechanism in CoCl2-induced apoptosis of rat PC12 cellsNeurosci Lett20043712–3859015519734
- SetaKASpicerZYuanYLuGMillhornDEResponding to hypoxia: lessons from a model cell lineSci STKE20022002146re1112189251
- VavilisTDelivanoglouNAggelidouEOxygen-Glucose Deprivation (OGD) Modulates the Unfolded Protein Response (UPR) and Inflicts Autophagy in a PC12 Hypoxia Cell Line ModelCell Mol Neurobiol201636570171226239244
- LeeMKangHJangSWCoCl2 induces PC12 cells apoptosis through p53 stability and regulating UNC5BBrain Res Bull201396192723651544
- BonoiuACBergeyEJDingHGold nanorod – siRNA induces efficient in vivo gene silencing in the rat hippocampusNanomedicine20116461763021718174
- GuerreroSArayaEFiedlerJLImproving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptideNanomedicine20105689791320735225
- GuerreroSHeranceJRRojasSSynthesis and in vivo evaluation of the biodistribution of a 18F-labeled conjugate gold-nanoparticle-peptide with potential biomedical applicationBioconjug Chem201223339940822284226
- LiMGuanYZhaoARenJQuXUsing Multifunctional Peptide Conjugated Au Nanorods for Monitoring β-amyloid Aggregation and Chemo-Photothermal Treatment of Alzheimer’s DiseaseTheranostics20177122996300628839459
- AduraCGuerreroSSalasEStable conjugates of peptides with gold nanorods for biomedical applications with reduced effects on cell viabilityACS Appl Mater Interfaces20135104076408523597259
- NikoobakhtBEl-SayedMAPreparation and Growth Mechanism of Gold Nanorods (NRs) Using Seed-Mediated Growth MethodChem Mater2003151019571962
- JanaNRGearheartLMurphyCJWet Chemical Synthesis of High Aspect Ratio Cylindrical Gold NanorodsJ Phys Chem B20011051940654067
- HuangDYangCWangYLiaoYHuangKPARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR gamma in cardiac fibroblastsCardiovasc Res20098119810718815186
- WangSKoolETOrigins of the large differences in stability of DNA and RNA helices: C-5 methyl and 2′-hydroxyl effectsBiochemistry19953412412541327535100
- SioudMSingle-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2′-hydroxyl uridines in immune responsesEur J Immunol20063651222123016609928
- BahadarHMaqboolFNiazKAbdollahiMToxicity of Nanoparticles and an Overview of Current Experimental ModelsIran Biomed J201620111126286636
- VirágLSzabóCThe therapeutic potential of poly(ADP-ribose) polymerase inhibitorsPharmacol Rev200254337542912223530
- AzzopardiDVStrohmBEdwardsADTOBY Study GroupModerate hypothermia to treat perinatal asphyxial encephalopathyN Engl J Med2009361141349135819797281
- RainaAPanditaAHarishRYachhaMJamwalATreating perinatal asphyxia with theophylline at birth helps to reduce the severity of renal dysfunction in term neonatesActa Paediatr201610510e448e45127173369
- LeeSJSonSYheeJYStructural modification of siRNA for efficient gene silencingBiotechnol Adv201331549150322985697
- LamJKChowMYZhangYLeungSWsiRNA Versus miRNA as Therapeutics for Gene SilencingMol Ther Nucleic Acids201549e25226372022
- McmanusMTSharpPAGene silencing in mammals by small interfering RNAsNat Rev Genet200231073774712360232
- ScaringeSAKitchenDKaiserRJMarshallWSPreparation of 5′-silyl-2′-orthoester ribonucleosides for use in oligoribonucleotide synthesisCurr Protoc Nucleic Acid Chem2004 Chapter 2:Unit 210
- VhoraIPatilSAmrutiyaJMisraALiposomes and Lipid Envelope-Type Systems for Systemic siRNA DeliveryCurr Pharm Des201521314541455526486141
- LengQWoodleMCLuPYMixsonAJAdvances in Systemic siRNA DeliveryDrugs Future200934972120161621
- GhoshPHanGdeMKimCKRotelloVMGold nanoparticles in delivery applicationsAdv Drug Deliv Rev200860111307131518555555
- GuoSHuangYJiangQEnhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyteACS Nano2010495505551120707386
- ElbakryAZakyALieblRRachelRGoepferichABreunigMLayer-by-layer assembled gold nanoparticles for siRNA deliveryNano Lett2009952059206419331425
- LiuHPierre-PierreNHuoQDynamic light scattering for gold nanorod size characterization and study of nanorod–protein interactionsGold Bull2012454187195
- RuffJHüwelSKoganMJSimonUGallaHJThe effects of gold nanoparticles functionalized with β-amyloid specific peptides on an in vitro model of blood-brain barrierNanomedicine20171351645165228285163
- MukherjeeSGhoshRNMaxfieldFREndocytosisPhysiol Rev19977737598039234965
- HuotariJHeleniusAEndosome maturationEmbo J201130173481350021878991
- TatipartiKSauSKashawSKIyerAKsiRNA Delivery Strategies: A Comprehensive Review of Recent DevelopmentsNanomaterials201774pii: E77
- LiuJLiJLiuNIn vitro studies of phospholipid-modified PAMAM-siMDR1 complexes for the reversal of multidrug resistance in human breast cancer cellsInt J Pharm20175301–229129928619457
- HuYBDammerEBRenRJWangGThe endosomallysosomal system: from acidification and cargo sorting to neurodegenerationTransl Neurodegener201541826448863
- OlmedoIArayaESanzFHow changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for beta-amyloid fibrilsBioconjug Chem20081961154116318510352
- SheteHKPrabhuRHPatravaleVBEndosomal escape: a bottleneck in intracellular deliveryJ Nanosci Nanotechnol201414146047424730275
- TanakaHNakataniTFurihataTIn Vivo Introduction of mRNA Encapsulated in Lipid Nanoparticles to Brain Neuronal Cells and Astrocytes via Intracerebroventricular AdministrationMol Pharm20181552060206729638135
- MaDEnhancing endosomal escape for nanoparticle mediated siRNA deliveryNanoscale20146126415642524837409
- LiJLiangHLiuJWangZPoly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapyInt J Pharm20185461–221522529787895
- PradesRGuerreroSArayaEDelivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptorBiomaterials201233297194720522795856
- KeaneyJCampbellMThe dynamic blood-brain barrierFebs J2015282214067407926277326
- MoralesPFiedlerJLAndrésSPlasticity of hippocampus following perinatal asphyxia: effects on postnatal apoptosis and neurogenesisJ Neurosci Res200886122650266218512760